Last Posted: Aug 04, 2015
- Risk of Cutaneous Squamous Cell Carcinoma Development in Renal Transplant Recipients Is Independent of TMC/EVER Alterations.
Burger Bettina, et al. Dermatology (Basel, Switzerland) 2015 9 (3) 245-52
- A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk.
Liang Caihua, et al. PloS one 2015 0 (4) e0123716
- Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.
Castro Felipe A, et al. International journal of cancer. Journal international du cancer 2012 1 (2) 349-55
- Epidermodysplasia verruciformis
From NCATS Genetic and Rare Diseases Information Center
- Four mutations in Epidermodysplasia verruciformis 1 (EVER1) gene are not contributors to susceptibility in RRP.
Donfack Joseph, et al. International journal of pediatric otorhinolaryngology 2006 7 (7) 1235-40
- Association of p53 arginine polymorphism with skin cancer.
de Oliveira Walmar Roncalli P, et al. International journal of dermatology 2004 7 (7) 489-93
- The role of p53 codon 72 and human papilloma virus status of cutaneous squamous cell carcinoma in the Swedish population.
Gustafsson Anna C, et al. Acta dermato-venereologica 2004 0 (6) 439-44
- Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with epidermodysplasia verruciformis.
de Oliveira Walmar Roncalli P, et al. Journal of the American Academy of Dermatology 2003 10 (4) 639-43
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.